← Human Trials & Peer-Reviewed Studies
High-Fiber Orange Juice as a Nutrition Supplement in Women: A Randomized, Double-Blind, Placebo-Controlled Study of Tolerance and Effectiveness.
Plain-language guide to PMID 24941951 (2015): double-blind randomized controlled trial of Dietary Fiber in 192 women.
Key Facts
- PMID
- 24941951
- Journal
- JPEN. Journal of parenteral and enteral nutrition
- Year
- 2015
- Study type
- Randomized Controlled Trial
- Authors
- Bergamasco C et al. (4 authors)
- DOI
- 10.1177/0148607114539703
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Dietary Fiber.
Using a double-blind, controlled, randomized study, the researchers assessed the efficiency and tolerance of a fiber-enriched orange juice to supplement fiber intake in women.
Who Took Part
The study group was 192 women.
By PubMed's age tags, the people studied were adults, women only.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
The women were allocated by chance, so the Dietary Fiber group and the comparison group should start out alike.
As a double-blind Dietary Fiber study, the assignments were hidden from both participants and investigators until the end.
Some women received a placebo instead of Dietary Fiber, giving a reference point.
Macronutrient, fiber, and energy intake were determined using a 3-day food record, validated food chemical composition databases, and the "Pro Diet" software.
What Was Measured
Using a double-blind, controlled, randomized study, the researchers assessed the efficiency and tolerance of a fiber-enriched orange juice to supplement fiber intake in women.
The subject headings attached to it are Citrus sinensis, Diet, Dietary Fiber, Dietary Supplements, Energy Intake, Feeding Behavior and Fruit.
The authors tagged it with the keywords orange juice and tolerance.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Dietary Fiber in 192 women.
The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.
The publication is from 2015 (JPEN. Journal of parenteral and enteral nutrition), a journal based in United States.
More context: all human trials.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.